| INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis J Cohen, J Carlet Critical care medicine 24 (9), 1431-1440, 1996 | 678 | 1996 |
| Gut-origin sepsis in the critically ill patient: pathophysiology and treatment SF Assimakopoulos, C Triantos, K Thomopoulos, F Fligou, I Maroulis, ... Infection 46, 751-760, 2018 | 181 | 2018 |
| Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission M Papadimitriou-Olivgeris, M Marangos, F Fligou, M Christofidou, ... Journal of antimicrobial chemotherapy 67 (12), 2976-2981, 2012 | 133 | 2012 |
| Maternal vaccination against pertussis: a systematic review of the recent literature D Gkentzi, P Katsakiori, M Marangos, Y Hsia, G Amirthalingam, PT Heath, ... Archives of Disease in Childhood-Fetal and Neonatal Edition 102 (5), F456-F463, 2017 | 125 | 2017 |
| A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies MN Gamaletsou, TJ Walsh, T Zaoutis, M Pagoni, M Kotsopoulou, ... Clinical Microbiology and Infection 20 (1), O50-O57, 2014 | 119 | 2014 |
| Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients M Papadimitriou-Olivgeris, E Drougka, F Fligou, F Kolonitsiou, ... Infection 42, 1013-1022, 2014 | 115 | 2014 |
| KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality M Papadimitriou-Olivgeris, M Marangos, F Fligou, M Christofidou, ... Diagnostic microbiology and infectious disease 77 (2), 169-173, 2013 | 111 | 2013 |
| Infectious complications in patients with lung cancer. KS Akinosoglou, K Karkoulias, M Marangos European Review for Medical & Pharmacological Sciences 17 (1), 2013 | 110 | 2013 |
| Native valve right sided infective endocarditis K Akinosoglou, E Apostolakis, M Marangos, G Pasvol European journal of internal medicine 24 (6), 510-519, 2013 | 107 | 2013 |
| Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin CO Onyeji, CH Nightingale, MN Marangos Infection 22, 338-338, 1994 | 104 | 1994 |
| Antimicrobial properties on non-antibiotic drugs in the era of increased bacterial resistance M Lagadinou, MO Onisor, A Rigas, DV Musetescu, D Gkentzi, ... Antibiotics 9 (3), 107, 2020 | 95 | 2020 |
| Prognosis of COVID-19: Changes in laboratory parameters M Lagadinou, EE Solomou, N Zareifopoulos, M Marangos, C Gogos, ... Age (yrs) 62 (13.4), 47-16.42, 2020 | 88 | 2020 |
| Tetanus: pathophysiology and management ME Ernst, ME Klepser, M Fouts, MN Marangos Annals of Pharmacotherapy 31 (12), 1507-1513, 1997 | 87 | 1997 |
| Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents ME Tyllianakis, AC Karageorgos, MN Marangos, AG Saridis, EE Lambiris The Journal of arthroplasty 25 (7), 1078-1082, 2010 | 84 | 2010 |
| SAPHO syndrome diagnosis and treatment: report of five cases and review of the literature C Matzaroglou, D Velissaris, A Karageorgos, M Marangos, ... The Open Orthopaedics Journal 3, 100, 2009 | 83 | 2009 |
| Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality M Papadimitriou-Olivgeris, F Fligou, C Bartzavali, A Zotou, A Spyropoulou, ... European Journal of Clinical Microbiology & Infectious Diseases 36, 1125-1131, 2017 | 80 | 2017 |
| Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis DP Nicolau, MN Marangos, CH Nightingale, R Quintiliani Antimicrobial agents and chemotherapy 39 (8), 1748-1751, 1995 | 79 | 1995 |
| Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries HIV-CAUSAL Collaborationa Clinical Infectious Diseases 54 (9), 1364-1372, 2012 | 73 | 2012 |
| Clinical pharmacokinetics of newer cephalosporins ME Klepser, MN Marangos, KB Patel, DP Nicolau, R Quintiliani, ... Clinical pharmacokinetics 28, 361-384, 1995 | 73 | 1995 |
| Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit M Papadimitriou-Olivgeris, M Marangos, M Christofidou, F Fligou, ... Scandinavian journal of infectious diseases 46 (9), 642-648, 2014 | 72 | 2014 |
